Posted in | News | Remote Monitoring

ATA 2014 to Feature iMDsoft’s Advanced Tele-ICU Solution, Mvcentral

iMDsoft is committed to providing tele-health solutions that ensure the best possible remote care.

The company’s tele-ICU solution, MVcentralTM, enables intensivists to provide care around the clock from a remote command center and communicate with the hospital-based clinical team. MVcentral will be presented at ATA 2014 in Maryland, May 18th to 20th.

MVcentral is designed to flag changes in patient condition, prioritize situations that require urgent attention and promote protocol compliance via decision support rules, enabling early intervention. Automated quality and compliance documentation audits ensures adherence with protocols and regulations. iMDsoft has significant expertise in critical care and offers MVcentral functionality across NICUs, PICUs and all types of adult ICUs.

At Lehigh Valley Health Network, MVcentral helped reduce mortality by 30% and reduce ventilator use in critically ill patients (Arch Intern Med. 2010). According to LVHN’s Dr. Matt McCambridge, “We have data that proves that MetaVision helps us improve patient safety and save more lives."

“MVcentral enables organizations to leverage specialist expertise and provide their patients with a superior level of care,” said Mike Myers, CEO of iMDsoft. “We are proud that our remote monitoring solution offers concrete value at a low cost of ownership.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.